Pfizer Reports Initial COVID-19 Vaccine In Clinical Tests 90 Percent Effective
NEW YORK - Pfizer and its German partner BioNTech SE gave the world an early Christmas present when they announced initial clinical studies show a COVID-19 vaccine was 90 percent effective. What’s more, in a press release, the companies said based on current projections the pharma companies expect to produce globally up to 50 million





